Track 24: Dermato-Oncology: Skin Cancer Therapies

Dermato-Oncology: Skin Cancer Therapies

ermato-oncology encompasses the study, diagnosis, and management of cutaneous malignancies, representing one of the most critical and rapidly advancing fields in dermatology. Skin cancers—including basal cell carcinoma, squamous cell carcinoma, and malignant melanoma—constitute the most common malignancies worldwide, with rising incidence linked to ultraviolet exposure, genetic susceptibility, and environmental factors. Early detection and effective therapeutic strategies are vital to improving survival rates and patient outcomes.

Advances in molecular biology and immuno-oncology have revolutionized the landscape of skin cancer therapy, enabling precision medicine approaches that target specific genetic and immunologic pathways. Targeted therapies such as BRAF and MEK inhibitors, and immune checkpoint inhibitors like anti–PD-1 and anti–CTLA-4 antibodies, have dramatically improved outcomes in advanced melanoma and non-melanoma skin cancers. These treatments exemplify the shift toward individualized therapy based on molecular profiling and tumor microenvironment modulation.

Surgical innovations—including Mohs micrographic surgery, image-guided excisions, and reconstructive techniques—remain central to achieving optimal oncologic control with superior cosmetic results. Non-surgical modalities, such as photodynamic therapy, radiotherapy, cryotherapy, and intralesional immunotherapy, continue to play vital roles in early-stage and palliative management. Furthermore, advances in artificial intelligence and digital dermoscopy are enhancing early diagnosis, risk assessment, and treatment monitoring.

The session on Dermato-Oncology: Skin Cancer Therapies will convene oncologists, dermatologists, surgeons, and researchers to explore the latest developments in cancer biology, immunotherapy, and translational research. Participants will gain in-depth knowledge of evolving therapeutic paradigms, emerging biomarkers, and integrative approaches that are redefining the standards of care in skin cancer management and survivorship.